glycohyodeoxycholic acid
Code | Size | Price |
---|
TAR-T8153-1mL | 1 mL * 10 mM (in DMSO) | £127.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T8153-20mg | 20mg | £159.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
glycohyodeoxycholic acid is a major metabolite of the secondary bile acid hyodeoxycholic acid in humans.
CAS:
13042-33-6
Formula:
C26H43NO5
Molecular Weight:
449.632
Pathway:
; Metabolism
Purity:
0.9982
SMILES:
C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Target:
Endogenous Metabolite
References
Sacquet E , Parquet M , Riottot M , et al. Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man[J]. Journal of Lipid Research, 1983, 24(5):604-613.
Mcsherry C K , Mosbach E H , Cohen B I , et al. Hyodeoxycholic acid: A new approach to gallstone prevention[J]. The American Journal of Surgery, 1985, 149(1):126-132.